Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a kidney transplant. Since the publication of the original Kidney Disease: Improving Global Outco...
Main Authors: | Jadoul, M, Berenguer, M, Doss, W, Fabrizi, F, Izopet, J, Jha, V, Kamar, N, Kasiske, B, Lai, C, Morales, J, Patel, P, Pol, S, Silva, M, Balk, E, Gordon, C, Earley, A, Di, M, Martin, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
by: Shlipak, MG, et al.
Published: (2020) -
Executive Summary
by: Burns, Daniel R.
Published: (2012) -
Executive Summary
by: Burns, Daniel R.
Published: (2012) -
Executive Summary
by: Burns, Daniel R.
Published: (2012) -
Executive Summary
by: Burns, Daniel R.
Published: (2011)